Lynch Group upgraded guidance for FY23 … you could say it’s blooming

Nick Sundich Nick Sundich, June 1, 2023

Lynch Group (ASX:LGL) hasn’t been the hottest ASX stock by any means, but it just upgraded guidance for FY23 at a time when so many other companies are downgrading it.

 

Do you need solid trading & investment ideas on ASX?

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Meet Lynch Group

Lynch Group is a wholesaler of flowers and potted plants in Australia and China. It was founded in 1915 by Greek immigrant Leo Lynch and after a century in the family, was sold to private equity in 2015 and listed in 2021 (unusually without the private equity owner selling).

The company’s promise was the growth potential in China but even in Australia considering the low proportion of flowers sold in supermarkets and how Lynch had a dominant position in the market. But it has struggled to penetrate the market in China and its shares have more than halved since listing. There has been speculation that it could be bought out by private equity – indeed, the company was made by the ASX to address the speculation.

 

Upgraded guidance

The company has just been through Mother’s Day, one of the biggest selling periods of the year. And in China, demand was rebounding following the country’s re-opening as well as a reduction in freight costs due to increased aircraft capacity. LGL previously guided to $36-$40m in FY23 EBITDA at a group level, but now expects $42-$43m. Lynch also told shareholders to expect a resumption of dividends at results time.

Nevertheless, this would be a decline from FY22 when it made $48m and this was a downgrade from the $59m the year before. The company had continued growing revenue, but costs had an impact on margins.

In any case, investors like the increased guidance with the stock up more than 13%!

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial will expire automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Kamala Harris stocks

Kamala Harris stocks: If Joe Biden’s VP wins the White House in 2024, which stocks will win?

With the US Presidential election now certain to be a Kamala Harris v Donald Trump showdown, we’ve looked at so-called…

South32

South32 (ASX:S32): Is it the dark horse amongst ASX 200 miners or have cyclones and commodity prices hit it too hard?

South32 (ASX:S32) began life as a spinoff from BHP back in 2015, capitalised at $9bn. In mid-2024, it is capped…

drug reimbursement

Here’s why drug reimbursement is so important for ASX healthcare stocks

Let’s take a look at the concept of drug reimbursement, something that is crucial for ASX healthcare stocks looking to…